A Study to Investigate the Effects of Impaired Hepatic Function on Velzatinib

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study evaluates the pharmacokinetics (PK), safety, and tolerability of velzatinib in participants with mild, moderate, and severe hepatic impairment (HI) and participants with normal hepatic function.
Epistemonikos ID: ff5c732b7e40b2a1d6ae6a137a2055d2aff54036
First added on: Oct 07, 2026